Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name ↓	B/G	Ingredients	Dosage	Form	Price
J02AC01	MYXEN	G	Fluconazole - 150mg	150mg	Tablet	255,970 L.L
J02AC01	MYXEN	G	Fluconazole - 50mg	50mg	Tablet	755,112 L.L
J02AC01	MYXEN	G	Fluconazole - 50mg/5ml	50mg/5ml	Granules for suspension	793,507 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	56,536,307 L.L
L04AA06	MYORA	G	Mycophenolate mofetil - 500mg	500mg	Tablet, film coated	3,643,157 L.L
L01FX02	MYLOTARG	BioTech	Gemtuzumab Ozogamicin - 4.5mg	4.5mg	Injectable powder	L.L
L01FX02	MYLOTARG	BioTech	Gemtuzumab Ozogamicin - 4.5mg	4.5mg	Injectable powder	748,160,090 L.L
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	L.L
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	20,324,991 L.L
S01FA06	MYDRIACYL	B	Tropicamide - 1%	1%	Drops solution	430,030 L.L
M03BX04	MYDOCALM	B	Tolperisone - 150mg	150mg	Tablet, film coated	839,902 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	325,210 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L
G01AF04	MYCODERM-V	G	Miconazole nitrate - 2%	2%	Cream	361,494 L.L
S03CA04	MYCICORT	G	Hydrocortisone acetate - 5mg, Neomycin sulfate - 5mg		Drops suspension	166,381 L.L
D07CA01	MYCICORT	G	Neomycin sulfate - 5mg/g, Hydrocortisone acetate - 10mg/g		Ointment	485,063 L.L
J02AX05	MYCAMINE	B	Micafungin (sodium) - 50mg	50mg	Injectable lyophilised powder for solution	13,170,341 L.L
L01FG01	MVASI	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	17,173,671 L.L
L01FG01	MVASI	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	58,035,926 L.L
M03BC51	MUSCEROL EXTRA	G	Caffeine - 15mg, Paracetamol - 450mg, Orphenadrine citrate - 35mg		Tablet, scored	267,489 L.L
M03BC51	MUSCEROL 3	G	Paracetamol - 450mg, Orphenadrine citrate - 35mg, Ibuprofen - 200mg		Tablet, film coated	593,850 L.L
M03BC51	MUSCEROL 2	G	Paracetamol - 450mg, Orphenadrine (citrate) - 35mg		Tablet, scored	177,899 L.L
J01DD08	MUREX 200	G	Cefixime - 200mg	200mg	Capsule	430,030 L.L
J01DD08	MUREX	G	Cefixime - 400mg	400mg	Capsule	679,984 L.L
J01DD08	MUREX	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	524,099 L.L
R05CB06	MUKORAL	G	Ambroxol - 30mg	30mg	Tablet	201,576 L.L
R05CB06	MUKORAL	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	341,336 L.L

...